EDCTP celebrates World Malaria Day!
On World Malaria Day 2021, EDCTP joins all partners in the ‘Zero Malaria – Draw the Line Against Malaria’ campaign towards the goal of malaria elimination. Towards malaria research & development, EDCTP has invested more than €150 million to support a portfolio of 64 research projects conducted by African-European consortia and research fellows in Africa.
These projects support the development of innovative products – diagnostics, drugs and vaccines – needed to manage, control and eliminate malaria. EDCTP funding progressed the development of the R21 vaccine that recently demonstrated greater than 75% protection in a recent phase II trial. The EDCTP malaria portfolio also includes studies on implementation of interventions and activities to strengthen health systems, essential to ensure successful roll-out of new and existing products, and to contribute to the malaria eradication agenda.
“We must not waver in our efforts to control and steadily move towards malaria eradication, despite the COVID-19 pandemic and other challenges. The recent exciting results from the clinical development of the R21 malaria vaccine in Burkina Faso bring us a step closer to a highly effective malaria vaccine. We remain committed to support the development of new and improved products for the diagnosis, prevention and treatment, as well as product-focused implementation research to ensure that these products reach the populations that need them most.”
Dr Michael Makanga, EDCTP Executive Director
For more about EDCTP funded malaria projects visit https://www.edctp.org/news/world-malaria-day-2021/
Articles
Edctp Fellow Awarded Wellcome Leap Grant For Tb Research
EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.
Applications Are Now Open For The Edctp Prizes 2027
Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.
The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.
Edctp Forum 2027: Calls For Abstracts, Scientific Symposia And Workshops Now Open
Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).
Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.
The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.